应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ADTX ADiTx Therapeutics
盘后交易 10-31 19:52:20 EDT
0.5550
+0.0034
+0.62%
盘后
0.5650
+0.0100
+1.80%
19:52 EDT
最高
0.5852
最低
0.5050
成交量
1,354万
今开
0.5852
昨收
0.5516
日振幅
14.54%
总市值
260.84万
流通市值
260.84万
总股本
469.98万
成交额
773.59万
换手率
288.09%
流通股本
469.98万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Aditxt(ADTX.US):2024年Q1财报实现营收7.968万美元,前值为21.841万美元;每股收益为-9.14美元,前值为-52.40美元。
智通财经 · 05-21
Aditxt(ADTX.US):2024年Q1财报实现营收7.968万美元,前值为21.841万美元;每股收益为-9.14美元,前值为-52.40美元。
Aditxt(ADTX.US):2024年Q1财报实现营收7.968万美元,前值为21.841万美元;每股收益为-9.14美元,前值为-52.
智通财经 · 05-21
Aditxt(ADTX.US):2024年Q1财报实现营收7.968万美元,前值为21.841万美元;每股收益为-9.14美元,前值为-52.
公司概况
公司名称:
ADiTx Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aditxt, Inc.于2017年9月28日根据特拉华州法律注册成立。该公司是一家临床前阶段的生命科学公司,致力于延长移植患者的生命和提高移植患者的生活质量。他们拥有独家全球许可证,用于将这种基于核酸的技术称为Apoptotic DNA Immunotherapy(ADi),该技术利用新的方法模仿他们的身体自然诱导对自身组织的耐受性。该公司计划开发用于器官移植,植皮和创伤愈合的ADi产品,最初的重点是皮肤移植和其他器官和组织同种异体移植。
发行价格:
--
{"stockData":{"symbol":"ADTX","market":"US","secType":"STK","nameCN":"ADiTx Therapeutics","latestPrice":0.555,"timestamp":1730404800000,"preClose":0.5516,"halted":0,"volume":13539545,"hourTrading":{"tag":"盘后","latestPrice":0.565,"preClose":0.555,"latestTime":"19:52 EDT","volume":92764,"amount":50909.95926239999,"timestamp":1730418731163},"delay":0,"floatShares":4699800,"shares":4699800,"eps":-1591.3079,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.0034,"latestTime":"10-31 19:52:20 EDT","open":0.5852,"high":0.5852,"low":0.505,"amount":7735905.6888379995,"amplitude":0.145395,"askPrice":0.5768,"askSize":20,"bidPrice":0.54,"bidSize":1100,"shortable":3,"etf":0,"ttmEps":-1591.3079,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1730419200000},"adr":0,"listingDate":1593489600000,"adjPreClose":0.5516,"preHourTrading":{"tag":"盘前","latestPrice":0.5818,"preClose":0.5516,"latestTime":"09:29 EDT","volume":2449380,"amount":1538604.99018,"timestamp":1730381389984},"postHourTrading":{"tag":"盘后","latestPrice":0.565,"preClose":0.555,"latestTime":"19:52 EDT","volume":92764,"amount":50909.95926239999,"timestamp":1730418731163},"volumeRatio":5.388068,"impliedVol":6.3423,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADTX/wiki","defaultTab":"wiki","newsList":[{"id":"2437143396","title":"Aditxt(ADTX.US):2024年Q1财报实现营收7.968万美元,前值为21.841万美元;每股收益为-9.14美元,前值为-52.40美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2437143396","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437143396?lang=zh_cn&edition=full","pubTime":"2024-05-21 06:05","pubTimestamp":1716242715,"startTime":"0","endTime":"0","summary":"Aditxt(ADTX.US):2024年Q1财报实现营收7.968万美元,前值为21.841万美元;每股收益为-9.14美元,前值为-52.40美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405210605188b1d4135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405210605188b1d4135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADTX"],"gpt_icon":0},{"id":"2437380174","title":"Aditxt(ADTX.US):2024年Q1财报实现营收7.968万美元,前值为21.841万美元;每股收益为-9.14美元,前值为-52.","url":"https://stock-news.laohu8.com/highlight/detail?id=2437380174","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437380174?lang=zh_cn&edition=full","pubTime":"2024-05-21 05:59","pubTimestamp":1716242340,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ADTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aditxt.com","stockEarnings":[{"period":"1week","weight":-0.4004},{"period":"1month","weight":-0.8714},{"period":"3month","weight":-0.9871},{"period":"6month","weight":-0.994},{"period":"1year","weight":-0.998},{"period":"ytd","weight":-0.9979}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0109},{"period":"3month","weight":0.0681},{"period":"6month","weight":0.1344},{"period":"1year","weight":0.3869},{"period":"ytd","weight":0.2203}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aditxt, Inc.于2017年9月28日根据特拉华州法律注册成立。该公司是一家临床前阶段的生命科学公司,致力于延长移植患者的生命和提高移植患者的生活质量。他们拥有独家全球许可证,用于将这种基于核酸的技术称为Apoptotic DNA Immunotherapy(ADi),该技术利用新的方法模仿他们的身体自然诱导对自身组织的耐受性。该公司计划开发用于器官移植,植皮和创伤愈合的ADi产品,最初的重点是皮肤移植和其他器官和组织同种异体移植。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.093384},{"month":2,"riseRate":0,"avgChangeRate":-0.153549},{"month":3,"riseRate":0.25,"avgChangeRate":-0.034533},{"month":4,"riseRate":0.25,"avgChangeRate":-0.206094},{"month":5,"riseRate":0.25,"avgChangeRate":-0.074716},{"month":6,"riseRate":0,"avgChangeRate":-0.280139},{"month":7,"riseRate":0.2,"avgChangeRate":-0.115338},{"month":8,"riseRate":0.2,"avgChangeRate":0.340652},{"month":9,"riseRate":0,"avgChangeRate":-0.532},{"month":10,"riseRate":0,"avgChangeRate":-0.317662},{"month":11,"riseRate":0.25,"avgChangeRate":-0.241533},{"month":12,"riseRate":0.5,"avgChangeRate":-0.051784}],"exchange":"NASDAQ","name":"ADiTx Therapeutics","nameEN":"ADiTx Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADiTx Therapeutics(ADTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADiTx Therapeutics,ADTX,ADiTx Therapeutics股票,ADiTx Therapeutics股票老虎,ADiTx Therapeutics股票老虎国际,ADiTx Therapeutics行情,ADiTx Therapeutics股票行情,ADiTx Therapeutics股价,ADiTx Therapeutics股市,ADiTx Therapeutics股票价格,ADiTx Therapeutics股票交易,ADiTx Therapeutics股票购买,ADiTx Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADiTx Therapeutics(ADTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}